Pharmacist Counseling & Self-Management Program for Asthma Patients in a Midwest Chain Pharmacy, USA (NCT07018583) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Pharmacist Counseling & Self-Management Program for Asthma Patients in a Midwest Chain Pharmacy, USA
84 participantsStarted 2025-08-01
Plain-language summary
This clinical trial aims to evaluate the effectiveness of a pharmacist-led counseling and self-management application program on improving asthma management outcomes among adult patients with asthma receiving care at a Midwest chain pharmacy in Iowa, United States.
The study investigates whether integrating the pharmacist counseling with self-management theory can enhance patients' medication adherence, asthma control, inhaler technique, and overall asthma awareness. These outcomes will be assessed at both 3 and 6 months after enrollment.
Participants will be randomly assigned to one of two arms. The intervention group, which will receive a comprehensive pharmacist-led counseling program supported by a mobile application ("Don R.Ph Application").
The control group, which will receive standard pharmacy care as per usual practice.
Who can participate
Age range25 Years – 64 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Adult patients with asthma are 25 - 64 years of age.
✓. Have been receiving medications from the pharmacy of either Inhaled Corticosteroids (ICS) or a fixed combination of ICS with a long-acting beta-agonist (bronchodilator) and regular patronage of the pharmacy for the previous six months.
✓. Confirmed diagnosis from either the physician's diagnosis or the patient's self-report.
✓. No respiratory comorbidities (i.e., COPD or lung diseases).
✓. Uses a smartphone (IOS or Android).
✓. Ability to communicate with the pharmacist in English.
✓. Volunteer to participate in the program for the period.
Exclusion criteria
✕. The adult patient with asthma aged \< 25 years or \> 64 years old.
✕. The patient with one of the following - coronary heart disease, severe hypertension, severe heart failure, severe musculoskeletal disorder, mental health condition, dementia, chronic obstructive lung disease, or COVID-19.